Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Musculoskeletal | Rheumatology | Nephrology | Family Medicine
 Disease Category: Gout (Hyperuricemia)
Location: United States, KY

Trial Information

Gout

The purpose of this study is to assess if colchicine will prevent gout attacks when subjects with gout begin taking allopurinol compared to subjects with gout taking a placebo and allopurinol.

Patient Inclusion Criteria:
Qualified participants must be at between the ages of 18 and 70 years old years old and have tophi and/or a history of gout attacks in at least 2 joints but no more than 3 joints. Other criteria also apply.

Patient Exclusion Criteria:
Qualified participants cannot have taken allopurinol, febuxostat, probenecid or sulfinpyrazone within the past 3 months and cannot have taken colchicine within the past 14 days.

Greta BonDurant or Leigh Anne Campbell
Central Kentucky Research Associates
3475 Richmond Rd., 3rd Floor
Lexington, KY 40509
Phone: 859-264-8999 or 1-800-898-1966
Email: gbondurant@ckrainc.com; lcampbell@ckrainc.com

View Map

Research Center Information: Central Kentucky Research Associates

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.